Molecular Neurodegeneration

Scope & Guideline

Championing open access for neurodegenerative research.

Introduction

Welcome to your portal for understanding Molecular Neurodegeneration, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationMOL NEURODEGENER / Mol. Neurodegener.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

Molecular Neurodegeneration focuses on the molecular and cellular mechanisms underlying neurodegenerative diseases, providing a platform for research that integrates various aspects of neurobiology and pathology.
  1. Mechanistic Insights into Neurodegeneration:
    The journal emphasizes understanding the fundamental biological processes that lead to neurodegenerative diseases, such as Alzheimer's, Parkinson's, and other tauopathies. This includes studies on protein misfolding, aggregation, and cellular stress responses.
  2. Immune System Interactions:
    Research often explores the role of the immune system, including microglial activation, neuroinflammation, and the effects of immune modulation on neurodegeneration, highlighting the complex interplay between the nervous and immune systems.
  3. Genetic and Epigenetic Factors:
    The journal covers genetic studies, including genome-wide association studies (GWAS) and investigations into specific genetic variants that contribute to neurodegenerative conditions, as well as epigenetic mechanisms that influence disease progression.
  4. Therapeutic Approaches and Biomarkers:
    Molecular Neurodegeneration presents studies on novel therapeutic strategies, including drug development, immunotherapy, and biomarker identification, aimed at improving diagnosis and treatment outcomes for neurodegenerative diseases.
  5. Cellular and Animal Models:
    The use of advanced cellular and animal models to study disease mechanisms and test therapeutic interventions is a consistent theme, allowing for a better understanding of human neurodegenerative conditions.
Recent publications in Molecular Neurodegeneration highlight several emerging themes that reflect the evolving landscape of neurodegenerative research.
  1. Role of the Gut-Brain Axis:
    There is an increasing focus on the gut microbiome's influence on neurodegeneration, particularly how gut-derived metabolites and inflammation affect brain health and disease progression.
  2. Single-Cell and Multi-Omics Approaches:
    The application of single-cell sequencing and multi-omics strategies is gaining traction, enabling researchers to dissect cellular heterogeneity and molecular pathways involved in neurodegenerative diseases.
  3. Targeted Protein Degradation:
    Emerging strategies involving targeted protein degradation technologies (e.g., AUTOTAC) are being explored as potential therapeutic approaches for clearing pathological protein aggregates.
  4. Advances in RNA Therapeutics:
    Research on RNA-based therapies, including antisense oligonucleotides and RNA modulation techniques, is on the rise, reflecting a shift towards innovative therapeutic modalities.
  5. Neuroinflammation and Microglial Function:
    A significant trend is the deeper exploration of neuroinflammation and the diverse roles of microglia in neurodegeneration, including their contributions to disease progression and potential as therapeutic targets.

Declining or Waning

While certain themes remain strong, others appear to be declining in prominence, reflecting shifts in research focus within the field of neurodegeneration.
  1. Traditional Neuropathology Studies:
    There seems to be a reduced emphasis on classical histopathological studies of neurodegenerative diseases, as research increasingly favors molecular and genetic approaches.
  2. Simple Model Systems:
    The use of basic model organisms or systems that do not adequately recapitulate human disease pathology appears to be waning, with a shift towards more complex models that better mimic human neurodegenerative processes.
  3. Generalized Biomarker Research:
    Research focused solely on generalized biomarkers without specific context or mechanistic insights is becoming less common, as the field moves towards more targeted and disease-specific biomarker studies.
  4. Broad Immunotherapy Approaches:
    There is a noticeable decline in publications focusing on broad-spectrum immunotherapies, with a shift towards more specific and mechanism-based immunomodulatory strategies.

Similar Journals

NATURE NEUROSCIENCE

Advancing the Frontiers of Neuroscience Research
Publisher: NATURE PORTFOLIOISSN: 1097-6256Frequency: 12 issues/year

NATURE NEUROSCIENCE is a premier journal published by NATURE PORTFOLIO, focusing on cutting-edge research in the field of neuroscience. With an esteemed impact factor that reflects its significance in the academic community, this journal occupies an exceptional place in the 2023 Q1 category for neuroscience (miscellaneous) and boasts a leading Scopus rank of #1 out of 113 in general neuroscience, placing it within the top 1st percentile. Since its inception in 1998, NATURE NEUROSCIENCE has consistently delivered high-quality, peer-reviewed articles that contribute to our understanding of the nervous system, driving innovation and scholarship across disciplines. Although it does not offer open access, the journal remains a vital resource for researchers, professionals, and students seeking to stay at the forefront of neuroscientific discovery and discussion. Its editorial commitment to excellence ensures that it continually shapes the trajectory of neuroscience research well into 2024 and beyond, making it an indispensable asset for anyone passionate about the brain and its complexities.

NEUROCHEMISTRY INTERNATIONAL

Connecting Researchers to Transform Neurochemical Understanding
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0197-0186Frequency: 10 issues/year

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

SYNAPSE

Exploring the Depths of Neural Communication
Publisher: WILEYISSN: 0887-4476Frequency: 12 issues/year

SYNAPSE, an esteemed journal in the field of Cellular and Molecular Neuroscience, is published by Wiley and serves as a vital platform for disseminating groundbreaking research in neuroscience. Established in 1987, this journal has been pivotal in exploring the intricate mechanisms governing synaptic function and neural communication, contributing to our understanding of the nervous system. With an ISSN of 0887-4476 and an E-ISSN of 1098-2396, SYNAPSE is indexed in Scopus and currently holds a Q4 quartile ranking in its category, reflecting its niche yet significant presence within the research community. Despite its recent ranking in the 21st percentile among its peers, the journal’s commitment to quality and innovation remains unwavering. It is published from Hoboken, New Jersey, and although it is not an open-access journal, it provides invaluable insights and critical reviews that are pivotal for researchers, professionals, and students alike who seek to advance their knowledge in the dynamic field of neuroscience. Join us in contributing to the ever-evolving discourse in cellular and molecular neuroscience through SYNAPSE.

JOURNAL OF MOLECULAR NEUROSCIENCE

Pioneering Research in Cellular and Molecular Neuroscience
Publisher: SPRINGERNATUREISSN: 0895-8696Frequency: 9 issues/year

Journal of Molecular Neuroscience, published by SpringerNature, is a critical resource for researchers and professionals in the dynamic field of neuroscience. With ISSN 0895-8696 and E-ISSN 1559-1166, this journal has established itself as a key player since its inception in 1989, covering a range of topics within Cellular and Molecular Neuroscience and Medicine (miscellaneous). Its impressive rankings, including being placed in the Q2 quartile for Medicine and Q3 for Cellular and Molecular Neuroscience, underscore its scholarly impact, featuring innovative research that informs and advances our understanding of neural processes. The journal does not currently operate under an open-access model, providing rich, peer-reviewed content geared towards academics and professionals seeking comprehensive analyses and breakthroughs in molecular neurobiology. With a publication window extending to 2024, the Journal of Molecular Neuroscience remains dedicated to enhancing the scientific community's knowledge landscape, making it an essential reference for those passionate about unraveling the complexities of the nervous system.

Life Science Alliance

Advancing the Frontiers of Life Sciences.
Publisher: LIFE SCIENCE ALLIANCE LLCISSN: Frequency: 6 issues/year

Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.

ACS Chemical Neuroscience

Illuminating the Chemical Foundations of Brain Activity.
Publisher: AMER CHEMICAL SOCISSN: 1948-7193Frequency: 12 issues/year

ACS Chemical Neuroscience, published by the American Chemical Society, is a premier journal dedicated to exploring the complex interactions between chemistry and neuroscience. With its ISSN 1948-7193 and a distinguished impact factor that positions it within the top quartiles across multiple categories, including Q1 in Biochemistry, Q2 in Cell Biology, and Q1 in Physiology, this journal serves as an essential platform for researchers engaged in cutting-edge studies from 2010 to 2024. Positioned within the top 15% of its field in Cognitive Neuroscience according to Scopus rankings, ACS Chemical Neuroscience strives to foster interdisciplinary collaboration, publishing significant advancements that integrate chemical concepts with neurological processes. Despite its traditional publication model, the journal is committed to maintaining rigorous peer-review standards and providing valuable insights that drive innovations in therapeutics and understanding the biochemical underpinnings of brain function. Researchers, professionals, and students alike will find in this journal a vital resource for the latest findings and methodologies in the dynamic intersection of chemistry and neuroscience.

NEUROMOLECULAR MEDICINE

Fostering Innovation in Cellular and Molecular Neuroscience
Publisher: HUMANA PRESS INCISSN: 1535-1084Frequency: 4 issues/year

NEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.

FASEB BioAdvances

Exploring Breakthroughs in Biological Research
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

Acta Neuropathologica Communications

Advancing the Frontiers of Neuropathology.
Publisher: BMCISSN: 2051-5960Frequency: 1 issue/year

Acta Neuropathologica Communications is a distinguished open-access journal published by BMC since 2013, focusing on the rapidly advancing fields of neurology, cellular and molecular neuroscience, and pathology. Located in the United Kingdom, this journal serves as a vital platform for researchers to disseminate significant findings that enhance our understanding of neurological disorders and their underlying mechanisms. With an impressive impact factor reflected in its Q1 ranking across multiple relevant categories, including Cellular and Molecular Neuroscience, Neurology (Clinical), and Pathology and Forensic Medicine, Acta Neuropathologica Communications stands out in the academic community for its rigorous peer-review process and commitment to high-quality research. The journal’s Scopus rankings highlight its global relevance, placing it in the top percentiles among leading research publications. Researchers, professionals, and students alike are encouraged to access and contribute to this essential resource, fostering a collaborative and informed approach to tackling the complexities of neuropathology and neuroscience.

IUBMB LIFE

Exploring the Depths of Cell Biology Research
Publisher: WILEYISSN: 1521-6543Frequency: 12 issues/year

IUBMB LIFE is a prestigious, peer-reviewed journal published by WILEY, dedicated to advancing the fields of biochemistry, molecular biology, and cell biology. With an impressive impact factor and consistently ranked in the Q1 and Q2 categories across multiple relevant disciplines—including Biochemistry, Genetics, and Clinical Biochemistry—this journal has established itself as a leading platform for disseminating innovative research and critical reviews that propel scientific discovery. The journal spans a converged publication period from 1999 to 2024, providing comprehensive insights into the dynamic landscape of biochemical research. Researchers, professionals, and students alike are invited to explore its Open Access options, ensuring that groundbreaking studies are accessible to a global audience. As it continues to shape the future of life sciences, IUBMB LIFE remains a vital resource for those seeking to enrich their understanding and contribute to these rapidly evolving fields.